SFPIA
MDCO

Stevens First Principles Investment Advisors’s Medicines Co MDCO Stock Holding History

Stevens First Principles Investment Advisors’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,000
Closed -$38K – 212
2015
Q3 		$38K Buy
+1,000
New +$35.1K 0.03% 127

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Stevens First Principles Investment Advisors's MDCO Position: Q4 2015 in Review

Stevens First Principles Investment Advisors sold out of Medicines Co (MDCO) in Q4 2015, closing a stake of 1,000 shares — an estimated $38K sold.

Stevens First Principles Investment Advisors first reported a position in MDCO in Q3 2015 and held it in 1 quarter. The position peaked at $38K in Q3 2015. 190 funds tracked by Wall St. Rank hold MDCO as of Q4 2015.

  • Stevens First Principles Investment Advisors reported no remaining Medicines Co position as of Q4 2015 after selling out during the quarter.
  • Stevens First Principles Investment Advisors sold 1,000 Medicines Co shares in Q4 2015, an estimated $38K.
  • Stevens First Principles Investment Advisors first reported a position in Medicines Co in Q3 2015 and held it in 1 quarter.
  • Stevens First Principles Investment Advisors's Medicines Co position peaked at $38K in Q3 2015.
  • 190 funds tracked by Wall St. Rank held Medicines Co as of Q4 2015.

Based on Stevens First Principles Investment Advisors's 13F filing for Q4 2015, filed 29 Jan 2016.